`

Mutabilis

Biotechnology Research

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$6.4M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Mutabilis

What does Mutabilis do?+

Mutabilis is a privately-held French biopharmaceutical company developing novel non-beta-lactam PBP-targeting antibacterial drugs called dabocins to treat the most difficult-to-treat Gram-negative bacterial infections. Dabocins are derived from the non-natural diazabicyclooctane scaffold and show a remarkable stability to beta-lactamase hydrolysis. Mutabilis team has unique expertise in the derivatization and characterization of this scaffold. Mutabilis pipeline includes EBL-1463, a novel single-agent intravenous antibiotic against carbapenem-resistant Enterobacterales also supported by ENABLE (ND4BB/IMI), and 2G-DAB, a 2nd generation dabocin program supported by the Repair Impact Fund and which aims to discover the next generation dabocin covering both Enterobacterales and non-fermenters. For more information, please...

What is Mutabilis's industry? +

Mutabilis operates in the Biotechnology research industry.

What is Mutabilis's revenue? +

Mutabilis's revenue is 11m - 100m

What is Mutabilis's company size? +

Mutabilis has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free